A Canadian compounding clinic rechecked its chemotherapy glove standard after a technician asked which drug the gloves had been tested against. The carton named a glove standard, ASTM D6319, while the supplier file showed no permeation test for any hazardous drug on the formulary. This review is a de-identified composite: the standards are real, the clinic details are representative.
Why did the clinic revisit its glove standard?
The trigger was small. A new hazardous drug joined the compounding formulary, and the technician preparing the workstation could not find that drug named in the standard.
The standard named a material and a thickness rather than a drug list. Nitrile examination gloves are commonly tested to ASTM D6319, which covers dimensions, tensile strength and watertightness — how a glove behaves in the carton, and nothing about drug permeation. So the clinic could show a glove that passed a holes test, and could not show a glove rated against the drugs its staff handle every week.
In Canada the decision belongs inside a documented risk assessment. The NAPRA model standards for pharmacy compounding of hazardous sterile preparations are the reference most sites work from, and a standard that names no drug does not close it.
What is breakthrough time and why does it matter?
Breakthrough time is the moment a challenge chemical is first detected on the inside surface of a glove. For chemotherapy drugs that measurement sits inside ASTM D6978, which assesses a glove's resistance to permeation by named drugs.
Permeation is not a hole. A glove can hold water all day and still let a drug molecule migrate through the polymer at the molecular level. Watertightness and permeation tests answer different questions, so strong physical test results do not imply any chemotherapy rating.
A breakthrough detection time belongs to one glove model and one drug, so a report covering drug A says nothing about drug B. The value comes from a laboratory method and has to be requested from the manufacturer, not read off a carton.
How do you match glove material to the drug handled?
Start from the drugs, then work back to the glove. Nitrile suits a long list of hazardous drugs and forms the base of most compounding stock in Canada, but the material name is only the entry ticket; the evidence is the report for the drug on your shelf.
| Question the clinic asked | Document that answers it | What the answer does not cover |
|---|---|---|
| Is this a nitrile examination glove? | ASTM D6319 sheet and lot certificate | Permeation by a chemotherapy drug |
| How fast does drug X cross this glove? | ASTM D6978 report naming drug X | Drugs absent from that report |
| Did the batch pass inspection? | AQL-based lot sampling records | The glove in your hand — AQL is a lot limit |
| Are these sterile pairs? | Sterility declaration and packaging | Chemical resistance, a separate axis |
The last row catches more buyers than it should: sterile and non-sterile are one axis, chemical resistance another. Our note on what ASTM D6319 certification actually means covers the physical side.
Where a formulary drug has no report, the clinic treats that as a decision for the pharmacy manager and the occupational health lead, not a substitution made at the bench. Double gloving and change-out routine follow the facility's PPE policy.
What changed after the review?
Four changes, and nothing dramatic. The chemotherapy workstations moved to a nitrile glove that carries a permeation report naming the formulary drugs, and the standard now lists drug names instead of a material description. The stock they selected is a 4.0 mil chemo-grade nitrile examination glove, picked because the supplier could produce the test report, not because of the number on the carton.
Cleaning and decontamination kept a heavier glove. A 6 mil nitrile glove stands up to repeated wiping and bucket work, so staff have less reason to reach into the chemotherapy box to scrub a counter. Our comparison of 4 mil, 6 mil and 8 mil nitrile gloves shows where each weight earns its place.
The reports went into the same binder as the safety data sheets. Receiving gained one line: when a lot arrives from a different production site, the model on the carton is matched against the report on file.
What should a compounding clinic document?
The file that survived the review held five things, none of them a marketing claim.
- The formulary drug list, with the approved glove model against each drug
- The ASTM D6978 report reference: drugs tested, test date, laboratory named
- The name and date of whoever approved the standard
- Training records showing staff were walked through the change
- Lot traceability on receipt, so a recall can be matched to stock
Two habits keep the file current. A review date tied to the formulary means adding a drug triggers a check rather than a scramble, and glove paperwork belongs with the purchasing record, where the AQL and glove quality guide for buyers sits alongside it. Sites also vet a readout system with a rapid reader seed trial before committing. Clinics holding glove stock across several locations can review wholesale ordering, while the learning hub collects the standards notes behind this review.
Related reading
- AQL explained: glove quality standards for buyers
- What ASTM D6319 certification actually means
- 4 mil vs. 6 mil vs. 8 mil nitrile gloves
- clinic consumables
Frequently Asked Questions
Do chemotherapy gloves have to be nitrile?
Not automatically. ASTM D6978 rates permeation for a named glove and a named drug, so the deciding document is the test report rather than the material on the carton. Nitrile suits a long list of hazardous drugs, and the report still has to name them.
What does ASTM D6978 actually test?
It measures how a glove resists permeation by named chemotherapy drugs and reports the result as a breakthrough detection time for each drug tested. Holes, tensile strength and sterility sit under other standards.
Is a thicker glove safer for hazardous drugs?
Thickness buys durability, not a permeation rating. Two gloves of the same thickness can behave very differently against the same drug, so ask for the ASTM D6978 report rather than comparing numbers on the carton.
How often should a clinic review its glove standard?
Tie the review date to the formulary, so adding a hazardous drug triggers a check that the report on file names it. The approval decision belongs with the pharmacy manager and the occupational health lead.
Where should glove test reports be kept?
In the purchasing and compliance file, matched to the glove model and, where possible, to the lot. Records that travel with the purchase order are the ones that can answer a question two years later.
CliniEco Medical is a licensed medical device establishment (MDEL #35334).
0 commentaire